$26.86
8.31% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US79957L1008
Symbol
SMTI

Sanara MedTech Inc Stock price

$26.86
-2.20 7.57% 1M
-7.65 22.17% 6M
-6.34 19.10% YTD
-0.97 3.49% 1Y
-0.69 2.50% 3Y
-0.13 0.48% 5Y
+17.86 198.44% 10Y
+1.86 7.44% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+2.06 8.31%

Key metrics

Basic
Market capitalization
$238.7m
Enterprise Value
$261.4m
Net debt
$22.7m
Cash
$20.7m
Shares outstanding
8.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.6 | 2.2
EV/Sales
2.9 | 2.5
EV/FCF
negative
P/B
6.5
Financial Health
Equity Ratio
44.7%
Return on Equity
-24.5%
ROCE
-8.7%
ROIC
-
Debt/Equity
1.2
Financials (TTM | estimate)
Revenue
$91.6m | $106.4m
EBITDA
$-2.8m | -
EBIT
$-7.3m | $-7.7m
Net Income
$-11.4m | $-14.2m
Free Cash Flow
$-2.3m
Growth (TTM | estimate)
Revenue
34.7% | 22.7%
EBITDA
-424.1% | -
EBIT
-60.1% | -97.7%
Net Income
-133.7% | -46.6%
Free Cash Flow
32.1%
Margin (TTM | estimate)
Gross
91.2%
EBITDA
-3.1% | -
EBIT
-7.9%
Net
-12.5% | -13.3%
Free Cash Flow
-2.5%
More
EPS
$-1.3
FCF per Share
$-0.3
Short interest
5.6%
Employees
108
Rev per Employee
$800.0k
Show more

Is Sanara MedTech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Sanara MedTech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Sanara MedTech Inc forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Sanara MedTech Inc forecast:

Buy
88%
Hold
13%

Financial data from Sanara MedTech Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
92 92
35% 35%
100%
- Direct Costs 8.08 8.08
6% 6%
9%
83 83
38% 38%
91%
- Selling and Administrative Expenses 79 79
32% 32%
87%
- Research and Development Expense 5.87 5.87
56% 56%
6%
-2.83 -2.83
424% 424%
-3%
- Depreciation and Amortization 4.44 4.44
11% 11%
5%
EBIT (Operating Income) EBIT -7.26 -7.26
60% 60%
-8%
Net Profit -11 -11
134% 134%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about Sanara MedTech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanara MedTech Inc Stock News

Neutral
GlobeNewsWire
28 days ago
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced it will report its second quarter 2025 financial resu...
Neutral
GlobeNewsWire
29 days ago
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus' technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expend...
Neutral
Seeking Alpha
2 months ago
Sanara MedTech's surgical revenue grew 26% year-over-year in Q1, with a gross margin of 92%. Surgical adjusted EBITDA was $2.7 million in Q1, while THP correspondingly posted a loss of $2 million. High debt levels and elevated interest expenses are key risks, along with the uncertainty surrounding the commercialization of THP.
More Sanara MedTech Inc News

Company Profile

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Head office United States
CEO Ron Nixon
Employees 108
Founded 1982
Website sanaramedtech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today